Setyawan Y. Nilotinib as the First Line Therapy in Managing Chronic Myelogenous Leukemia. eCl [Internet]. 2021 Mar. 21 [cited 2024 Apr. 25];9(2):342-50. Available from: https://ejournal.unsrat.ac.id/v3/index.php/eclinic/article/view/32699